These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15034580)

  • 1. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating.
    Bienengraeber M; Olson TM; Selivanov VA; Kathmann EC; O'Cochlain F; Gao F; Karger AB; Ballew JD; Hodgson DM; Zingman LV; Pang YP; Alekseev AE; Terzic A
    Nat Genet; 2004 Apr; 36(4):382-7. PubMed ID: 15034580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart.
    Alekseev AE; Hodgson DM; Karger AB; Park S; Zingman LV; Terzic A
    J Mol Cell Cardiol; 2005 Jun; 38(6):895-905. PubMed ID: 15910874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac KATP channels in health and disease.
    Kane GC; Liu XK; Yamada S; Olson TM; Terzic A
    J Mol Cell Cardiol; 2005 Jun; 38(6):937-43. PubMed ID: 15910878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex.
    Bienengraeber M; Alekseev AE; Abraham MR; Carrasco AJ; Moreau C; Vivaudou M; Dzeja PP; Terzic A
    FASEB J; 2000 Oct; 14(13):1943-52. PubMed ID: 11023978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity.
    Park S; Lim BB; Perez-Terzic C; Mer G; Terzic A
    J Proteome Res; 2008 Apr; 7(4):1721-8. PubMed ID: 18311911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human K(ATP) channelopathies: diseases of metabolic homeostasis.
    Olson TM; Terzic A
    Pflugers Arch; 2010 Jul; 460(2):295-306. PubMed ID: 20033705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
    Fang K; Csanády L; Chan KW
    J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first nucleotide binding domain of the sulfonylurea receptor 2A contains regulatory elements and is folded and functions as an independent module.
    de Araujo ED; Ikeda LK; Tzvetkova S; Kanelis V
    Biochemistry; 2011 Aug; 50(31):6655-66. PubMed ID: 21714514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
    Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
    Hosy E; Dérand R; Revilloud J; Vivaudou M
    J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
    Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntaxin-1A inhibits KATP channels by interacting with specific conserved motifs within sulfonylurea receptor 2A.
    Chao C; Liang T; Kang Y; Lin X; Xie H; Feng ZP; Gaisano HY
    J Mol Cell Cardiol; 2011 Nov; 51(5):790-802. PubMed ID: 21884702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit.
    Tammaro P; Ashcroft FM
    J Physiol; 2007 Nov; 584(Pt 3):743-53. PubMed ID: 17855752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
    Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cantú syndrome is caused by mutations in ABCC9.
    van Bon BW; Gilissen C; Grange DK; Hennekam RC; Kayserili H; Engels H; Reutter H; Ostergaard JR; Morava E; Tsiakas K; Isidor B; Le Merrer M; Eser M; Wieskamp N; de Vries P; Steehouwer M; Veltman JA; Robertson SP; Brunner HG; de Vries BB; Hoischen A
    Am J Hum Genet; 2012 Jun; 90(6):1094-101. PubMed ID: 22608503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-sensitive potassium channels: metabolic sensing and cardioprotection.
    Zingman LV; Alekseev AE; Hodgson-Zingman DM; Terzic A
    J Appl Physiol (1985); 2007 Nov; 103(5):1888-93. PubMed ID: 17641217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1.
    Flagg TP; Kurata HT; Masia R; Caputa G; Magnuson MA; Lefer DJ; Coetzee WA; Nichols CG
    Circ Res; 2008 Dec; 103(12):1458-65. PubMed ID: 18974387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
    Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
    J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of rabbit Kir6.1, SUR2A, and SUR2B: possible candidates for a renal K(ATP) channel.
    Brochiero E; Wallendorf B; Gagnon D; Laprade R; Lapointe JY
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F289-300. PubMed ID: 11788443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.